Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-23

Clinical Trial Update: A Randomized Trial of 4% Nebulized Lignocaine vs. 10% Lignocaine Spray in Patients Undergoing Flexible Bronchoscopy [Phase 2, Phase 3]

View source ↗

Summary

A randomized trial comparing 4% nebulized lignocaine to 10% lignocaine spray for anesthesia during flexible bronchoscopy (Phase 2/3; completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • lignocaine 4% nebulized (lignocaine)
  • lignocaine spray 10% (lignocaine)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Patients With Indication for Flexible Bronchoscopy | Phase 2, Phase 3 | Status: COMPLETED